Skip to main content
Year archive

LifeTech Scientific Corporation — 2025 filings

All 40 regulatory filings released by LifeTech Scientific Corporation (1302) in 2025, sourced directly from the official regulator.

40 Filings
2025 Period
2025 filings (40)
Filing Released Lang
CONNECTED TRANSACTION - SHARE PURCHASE PURSUANT TO SHARE AWARD SCHEME
Regulatory Filings
2025-12-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025
Regulatory Filings
2025-12-02 English
List of Directors and their Roles and Functions
Board/Management Information
2025-11-21 English
CHANGE OF DIRECTORS AND COMPOSITION OF BOARD COMMITTEES
Board/Management Information
2025-11-21 English
VOLUNTARY ANNOUNCEMENT - G-Branch TM Thoracoabdominal Artery Stent Graft System Obtained Official Registration Approval from the China NMPA
Regulatory Filings
2025-11-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025
Regulatory Filings
2025-11-05 English
Voluntary Announcement - Publication of the Two-Year Follow-Up Results of Phase II Clinical Study and Phase III Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
Regulatory Filings
2025-10-29 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025
Regulatory Filings
2025-10-06 English
Notification Letter and Request Form for Non-Registered Shareholders
Report Publication Announcement
2025-09-10 English
Notification Letter and Reply Form for Registered Shareholders
Report Publication Announcement
2025-09-10 English
INTERIM REPORT 2025
Interim / Quarterly Report H1 2025
2025-09-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Regulatory Filings
2025-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report H2 2025
2025-08-29 English
VOLUNTARY ANNOUNCEMENT - Admission of Innovative Medical Devices in respect of Congenital Heart Defect Occluder into Special Examination and Approval Procedure
Regulatory Filings
2025-08-22 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-08-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2025
Regulatory Filings
2025-08-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2025
Regulatory Filings
2025-07-03 English
VOLUNTARY ANNOUNCEMENT - CAPITAL INCREASE AND STRATEGIC INVESTMENT IN AFFECTOR MEDTECH (SUZHOU) LTD.
Capital/Financing Update
2025-06-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025
Regulatory Filings
2025-06-04 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2025
Declaration of Voting Results & Voting Rights Announcements
2025-05-28 English
List of Directors and their Roles and Functions
Governance Information
2025-05-23 English
CHANGE IN COMPOSITION OF BOARD COMMITTEE
Board/Management Information
2025-05-23 English
Voluntary Announcement - Aortic Arch Stent Graft System Obtained Official Registration Approval from the China NMPA
Regulatory Filings
2025-05-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025
Share Issue/Capital Change
2025-05-08 English
Notification Letter and Request Form For Non-Registered Holders
Report Publication Announcement
2025-04-25 English
Notification Letter and Reply Form For Registered Holders
Report Publication Announcement
2025-04-25 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-25 English
(1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND (3) NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-25 English
Proxy Form for use at the Annual General Meeting to be held on Wednesday, 28 May 2025 or any adjournment thereof
Proxy Solicitation & Information Statement
2025-04-25 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024
Environmental & Social Information
2025-04-25 English
ANNUAL REPORT 2024
Annual Report FY 2024
2025-04-25 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025
Share Issue/Capital Change
2025-04-07 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release FY 2024
2025-03-28 English
Voluntary Announcement - Pre-market Clinical Trial of LAmbreTM Plus Left Atrial Appendage Closure System Obtained Medical Insurance Coverage in the US
Regulatory Filings
2025-03-21 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-03-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025
Regulatory Filings
2025-03-05 English
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT
Regulatory Filings
2025-02-27 English
Voluntary Announcement - AnkuraTM Aortic Stent Graft System Obtained Official Registration Approval from the China NMPA
Regulatory Filings
2025-02-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025
Regulatory Filings
2025-02-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
Regulatory Filings
2025-01-03 English